YJL cropped.jpg

Yucynthia A. Jean-Louis, MPH, MBA

Chief Business Officer

Yucynthia Jean-Louis is an accomplished business development executive with over thirty years of experience in the pharmaceutical and biotechnology industry.  Yucynthia has successfully negotiated over 100 transactions on both the buy side and sell side.  Since 2015, she has been serving as Managing Partner at Jean-Louis Warner & Associates, LLC, a boutique consulting firm providing consulting services primarily to biotechnology companies to create executable business development strategies and structure and negotiate business transactions.  Previously, Yucynthia served as Executive Director, Corporate Licensing at Merck for 11 years. In that role, she successfully negotiated deals in several therapeutic areas, and has in-depth knowledge and expertise in oncology and immunotherapy.  Yucynthia led the negotiating team for the groundbreaking collaboration between Merck and AstraZeneca which received the Scrip Award for “Best Partnership Alliance.”  She was the chief architect of the innovative clinical collaborations investigating Merck’s novel anti-PD-1 immunotherapeutic, KEYTRUDA®, with investigational compounds and marketed products.  She was also responsible for negotiating Merck’s agreements for vaccines, biologics, neuroscience, and platform technologies as well as agreements in personalized medicine for companion diagnostics in oncology and neuroscience.  Prior to that, she spent 13 years working in roles of increasing responsibility in marketing at Merck, including launching Singulair® in allergic rhinitis, the first billion-dollar asthma medication, and at the vaccine joint venture formed by Merck and Pasteur Merieux, responsible for the entire live viral vaccine franchise in Europe while based in France.  Early in her career, Yucynthia worked as a basic research scientist at the Centers for Disease Control and Prevention laboratories in Atlanta and at the University of Washington in Seattle.  Yucynthia received her BS in Microbiology from the University of Louisiana at Lafayette, and her MPH in Health Policy and Planning and MBA in Strategy and General Management from Emory University in Atlanta.